1. Home
  2. ASMB vs ATLX Comparison

ASMB vs ATLX Comparison

Compare ASMB & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ATLX
  • Stock Information
  • Founded
  • ASMB 2005
  • ATLX 2011
  • Country
  • ASMB United States
  • ATLX Brazil
  • Employees
  • ASMB N/A
  • ATLX N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ASMB Health Care
  • ATLX Industrials
  • Exchange
  • ASMB Nasdaq
  • ATLX Nasdaq
  • Market Cap
  • ASMB 84.5M
  • ATLX 90.1M
  • IPO Year
  • ASMB 2010
  • ATLX N/A
  • Fundamental
  • Price
  • ASMB $10.03
  • ATLX $3.99
  • Analyst Decision
  • ASMB Strong Buy
  • ATLX Strong Buy
  • Analyst Count
  • ASMB 3
  • ATLX 2
  • Target Price
  • ASMB $33.00
  • ATLX $22.25
  • AVG Volume (30 Days)
  • ASMB 37.9K
  • ATLX 138.8K
  • Earning Date
  • ASMB 05-07-2025
  • ATLX 05-14-2025
  • Dividend Yield
  • ASMB N/A
  • ATLX N/A
  • EPS Growth
  • ASMB N/A
  • ATLX N/A
  • EPS
  • ASMB N/A
  • ATLX N/A
  • Revenue
  • ASMB $28,520,000.00
  • ATLX $748,654.00
  • Revenue This Year
  • ASMB $10.82
  • ATLX $20,462.24
  • Revenue Next Year
  • ASMB N/A
  • ATLX $37.63
  • P/E Ratio
  • ASMB N/A
  • ATLX N/A
  • Revenue Growth
  • ASMB 298.16
  • ATLX N/A
  • 52 Week Low
  • ASMB $7.75
  • ATLX $3.54
  • 52 Week High
  • ASMB $19.93
  • ATLX $17.72
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 48.99
  • ATLX 32.51
  • Support Level
  • ASMB $7.90
  • ATLX $3.54
  • Resistance Level
  • ASMB $10.36
  • ATLX $4.10
  • Average True Range (ATR)
  • ASMB 0.85
  • ATLX 0.41
  • MACD
  • ASMB 0.21
  • ATLX -0.05
  • Stochastic Oscillator
  • ASMB 86.04
  • ATLX 23.57

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

Share on Social Networks: